(Q38002686)

English

Where rilpivirine meets with tenofovir, the start of a new anti-HIV drug combination era.

scientific article published on 05 April 2012

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22504027

retrieved

26 August 2017

title

Where rilpivirine meets with tenofovir, the start of a new anti-HIV drug combination era. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

26 August 2017

1 reference

ChEBI release 2020-05-28

1 reference

Erik De Clercq

1

0 references

language of work or name

English

0 references

publication date

5 April 2012

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22504027

retrieved

26 August 2017

published in

Biochemical Pharmacology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22504027

retrieved

26 August 2017

volume

84

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22504027

retrieved

26 August 2017

issue

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22504027

retrieved

26 August 2017

page(s)

241-248

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22504027

retrieved

26 August 2017

Identifiers

DOI

10.1016/J.BCP.2012.03.024

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22504027

retrieved

26 August 2017

PubMed publication ID

22504027

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22504027

retrieved

26 August 2017

(Q38002686)

Where rilpivirine meets with tenofovir, the start of a new anti-HIV drug combination era.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)